1.
Global burden of blood-pressure-related disease, 2001
by Lawes, Carlene MM, PhD
The Lancet (British edition), 2008, Vol.371 (9623), p.1513-1518
2.
Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment
by Danaei, Goodarz
The Lancet (British edition), 2006, Vol.368 (9548), p.1651-1659
3.
Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk
by Murray, Christopher JL
The Lancet (British edition), 2003-03-01, Vol.361 (9359), p.717-725
4.
Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk
by Jackson, Rod
The Lancet (British edition), 2005-01-29, Vol.365 (9457), p.434-441
5.
Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk
by Jackson, Rod
The Lancet (British edition), 2005, Vol.365 (9457), p.434-441
6.
Treating individuals 5: treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk
by Jackson, Rod
The Lancet (British edition), 2005-01-29, Vol.365 (9457), p.434
7.
Blood Pressure Indices and Cardiovascular Disease in the Asia Pacific Region: A Pooled Analysis
by Lawes, Carlene M M
Hypertension (Dallas, Tex. 1979), 2003-07, Vol.42 (1), p.69-75
8.
Global burden of blood-pressure-related disease, 2001. Commentary
by MACMAHON, Stephen
The Lancet (British edition), 2008, Vol.371 (9623)
9.
Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration : comparative risk assessment. Commentary
by AVENDANO, Mauricio
The Lancet (British edition), 2006, Vol.368 (9548)
Filter electronic articles 9 Hits
Remove Filters
